Gara Jalqabaatti › Kansaarii Pirostaatikii Itti Falmu › Washington
Qorannoo klinikaalii Kansaarii Pirostaatikii Itti Falmu Washington keessatti
Qorannoo 6 Kansaarii Pirostaatikii Itti Falmu f Washington keessatti hirmaatuu jiru.
Magaalota Washington keessatti
Takkalaa qorannoo (Ingiliffa)
A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
- VA Puget Sound Healthcare System, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
- University of Washington, Seattle
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Dhiroota · Haaromfame 25-Ful-2026 · NCT07164443A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
- Fred Hutch Cancer Center Sloan Clinic 2, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Ful-2026 · NCT07225946A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
- Fred Hutchinson Cancer Center ( Site 0013), Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT06863272Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site Number: 400, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Ful-2026 · NCT05997615A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
- Swedish Cancer Institute, Seattle
- Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT04104776A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
- Fred Hutchinson Cancer Center, Seattle
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Dhiroota · Haaromfame 10-Hag-2026 · NCT06067841Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.